O maior índice de massa corporal e a presença de anticorpos antifármacos predizem a interrupção no uso de agentes anti‐TNF em pacientes sul‐coreanos com espondiloartrite axial

Our result suggests that the presence of ADAbs against adalimumab and infliximab as well as a higher BMI can predict subsequent drug discontinuation in axial SpA patients.